Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.
Clinical trial NCT03696342 · TERMINATED
Trial details
- NCT number
- NCT03696342
- Sponsor
- Laboratorios Sophia S.A de C.V.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2020-03-24
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.